What labs should a men’s testosterone clinic require before treatment?

AUA guidance diagnoses testosterone deficiency only with symptoms plus two early-morning total testosterone results, using a threshold near 300 ng/dL as a reasonable cutoff. Endocrine Society also requires consistently low morning levels and an evaluation of cause. A single afternoon fingerstick or a saliva kit is not that standard. Hematocrit and, when appropriate, PSA belong in the baseline conversation.

Which conditions should stop or delay systemic estrogen?

Unexplained vaginal bleeding, suspected or known hormone-sensitive breast cancer that has not been cleared with oncology, active or prior unprovoked VTE in many cases, and pregnancy are core stops. NAMS and Endocrine Society treat contraindications as individual but non-optional. A clinic that says bioidentical estrogen cannot affect breast tissue or clots is not following those documents. Local vaginal estrogen is a different, narrower discussion.

Are hormone pellets a red flag by themselves?

Pellets are hard to reverse if levels run high, and many are compounded. They can be used thoughtfully; they become a red flag when they are the only product, inserted on visit one, or titrated without a bleeding or hematocrit plan. Ask what labeled patch, gel, or oral option they would use if you refuse implantation. A mill that sells insertion volume over monitoring is the problem.

Do I need a 12-hormone saliva panel to start menopause therapy?

No. NAMS considers saliva, urine, and serial multi-hormone panels unreliable for dosing menopausal hormone therapy. Symptom history, uterus status, and contraindication review drive the prescription. A patch does not require a mystery dashboard. Extra testing that only justifies a custom compound is a business model. Bring prior mammogram dates and a bleeding history instead.

How to Choose an HRT Clinic

What “good” looks like

A good HRT clinic treats sex hormones as drugs with indications, contraindications, and follow-up. For menopause, that means bothersome vasomotor or genitourinary symptoms, a uterus-status plan, and a risk talk that includes venous thromboembolism and breast-cancer history. NAMS 2022 still calls hormone therapy the most effective treatment for vasomotor symptoms for appropriate candidates. It does not call “suboptimal hormones for longevity” a diagnosis.

For men, good care looks like AUA and Endocrine Society diagnosis: symptoms plus repeated early-morning testosterone, then a look at cause—sleep apnea, opioids, pituitary disease, obesity—not a same-day injection because an afternoon number looked low. Monitoring includes hematocrit, symptoms, fertility goals, and prostate-aware PSA decisions. Treatment aims at mid-range levels and safer routes when they fit, not at a bodybuilding number.

Good clinics prefer FDA-approved products when they exist. ACOG and NAMS advise against routine compounded BHRT. They still take a bleeding history, order indicated mammography, and tell you how to reach someone if spotting, chest pain, or a hematocrit spike appears. Pellets, if used, are a last-line reversible-poor option with a named reason—not the inventory that pays the rent.

Good care is licensed and local enough for complications. A tele-pellet mill that never examines breasts or testes and never sees you for bleeding is not a complete clinic. Cash-pay is common. Payment method does not excuse missing the medical parts.

Credentials and scope to verify

Confirm an active medical, NP, or PA license and whether a physician supervises protocolized care. Relevant backgrounds include endocrinology, gynecology, urology, menopause-focused internal medicine, or another clinician who actually manages hormones. A weekend certificate is not a specialty. Check the state board for discipline.

Ask who prescribes, who inserts pellets, who reviews labs, and who sees postmenopausal bleeding. Endometrial evaluation is gynecologic care. A high PSA or a prostate nodule is urologic care. Endocrine Society testosterone guidance recommends against starting therapy in men with active prostate or breast cancer, very high PSA without evaluation, elevated hematocrit, or recent myocardial infarction or stroke, among other conditions. The clinic should know that list without a sales pause.

Verify the pharmacy path. If they compound, get the pharmacy name and 503A versus 503B status. If they only insert pellets, ask which labeled gel or patch they would use instead. FDA menopause pages and compounding pages exist so you can compare a labeled insert with a custom jar.

Scope also means what they will not treat. Unexplained bleeding, pregnancy, and suspected breast cancer are stop signs. A clinic that starts systemic estrogen the same day as a first abnormal mammogram is outside good practice. So is testosterone for a man planning near-term fertility without counseling that exogenous testosterone can suppress spermatogenesis.

Questions to ask

What diagnosis are you treating, in one sentence?
What labeled product would you use if I refuse compounding and pellets?
How do you confirm hypogonadism—how many morning total testosterone tests?
If I have a uterus, exactly how do you protect the endometrium?
How do you screen for VTE, stroke, and personal or family breast-cancer history?
What is the plan for postmenopausal bleeding or a hematocrit that climbs?
Who do I call after hours, and when would you refer to gynecology, urology, or oncology?
What monitoring interval do you use, and what result would make you stop?

Listen for specific answers. “We optimize your unique curve” is not a diagnosis. “We always use pellets because they are steadier” is a product preference. “We do not need mammograms because this is bioidentical” is a walk-away sentence. NAMS rejects saliva-only titration; if the visit cannot start without a twelve-hormone kit, you are in a testing business.

Ask about fertility, sleep apnea, and medications that lower testosterone. Ask whether they will coordinate with your primary clinician. Hormone therapy changes other care. Isolation is a quality problem.

Red flags

Same-day pellets or injections before history, exam, and indicated labs.
One afternoon testosterone or a saliva panel as the only diagnostic test.
Guarantees about weight loss, anti-aging, or cancer prevention.
“Natural so no clot or breast risk.”
No bleeding protocol and no hematocrit plan.
Refusal to name the compounder or to offer any FDA-approved alternative.
Pressure to buy a yearly insertion package before you know how you respond.
Advice to skip mammography, colonoscopy, or your oncologist.

A pellet mill is a business that measures success in insertions. You can recognize it when follow-up is another implant, not a visit about sleep, fertility, or bleeding. High-normal marketing levels with rising hematocrit and no pause are another tell. Walk if they treat contraindications as paperwork you can initial away.

Cost, time, and logistics

Price the year: consult, labs, medication or insertions, ultrasound if bleeding occurs, and extra visits when a dose is wrong. Labeled generics can be far cheaper than membership compounding. Insurance may cover indicated menopause therapy or testosterone for documented deficiency and still leave cash programs uncovered. Ask for CPT and medication names in writing.

Time includes morning lab draws, a follow-up at a few months, and faster access if you bleed or feel short of breath. Pellets save daily dosing and cost reversibility. Gels and patches cost daily adherence and buy a faster stop. Choose the logistics you can actually live with.

Travel only if the receiving clinician will own complications. Shipping pellets across state lines does not replace an exam. If you use telehealth, confirm they are licensed where you live and that someone local can see you for breast, pelvic, or prostate problems.

Set a stop rule before you start. If symptoms do not change after a reasonable labeled-product trial, reassess the diagnosis—sleep, thyroid, depression, medications—rather than stacking DHEA and extra testosterone. Good HRT clinics stay boring: indication, approved product when possible, contraindications, and monitoring. That boredom is the feature.

How to Choose an HRT Clinic

What “good” looks like

Credentials and scope to verify

Questions to ask

Red flags

Cost, time, and logistics

Frequently Asked Questions

References

Guides

For Providers

Company